You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HM781-36B

Showing 1 - 25 of 2,240
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

Recruiting
  • EGFR Exon 20 Mutation
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial (Poziotinib

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Poziotinib Hydrochloride
  • 1429757-68-5, HM781-36B, NOV-1201 Hydrochloride, NOV120101 Hydrochloride, Poziotinib HCl, POZIOTINIB HYDROCHLORIDE
  • (no location specified)
Jul 18, 2022

Metastatic Breast Cancer Trial in Korea, Republic of (NOV120101 (Poziotinib))

Completed
  • Metastatic Breast Cancer
  • NOV120101 (Poziotinib)
  • Cheongju-si, Chungcheongbuk-do, Korea, Republic of
  • +6 more
Jan 5, 2022

Metastatic Breast Cancer Trial in Seoul (Poziotinib)

Completed
  • Metastatic Breast Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jul 1, 2020

Breast Cancer Trial in United States (Poziotinib)

Completed
Has Results
  • Breast Cancer
  • Huntsville, Alabama
  • +34 more
Feb 28, 2022

NSCLC Trial in Winter Haven (Poziotinib, Docetaxel)

Suspended
  • NSCLC
  • Winter Haven, Florida
    Bond Clinic, P.A.
Jan 27, 2023

NSCLC Trial in China, Korea, Republic of (Poziotinib)

Terminated
  • NSCLC
  • Beijing, China
  • +25 more
Nov 16, 2020

HNSCC Trial in Seoul (HM781-36B)

Unknown status
  • HNSCC
  • HM781-36B
  • Seoul, Korea, Republic of
    Yonsei University
Mar 14, 2019

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer, Melanoma Trial in Worldwide (MGC018, retifanlimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +5 more
  • MGC018
  • retifanlimab
  • Santa Monica, California
  • +19 more
Feb 14, 2022

B-cell Non-Hodgkin Lymphoma (NHL) Trial in Worldwide (Odronextamab)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (NHL)
  • Chicago, Illinois
  • +122 more
Apr 1, 2022

Acute Ischemic Stroke Trial in China (rt-PA, rhTNK-tPA)

Completed
  • Acute Ischemic Stroke
  • Hefei, Anhui, China
  • +60 more
Jan 13, 2023

NSCLC Trial in Worldwide (Alectnib, Cisplatin, Vinorelbine)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Chicago, Illinois
  • +140 more
Jan 20, 2023

HER2 Gene Mutation, Adenocarcinoma Lung Stage IV Trial in Seoul (Poziotinib)

Completed
  • HER2 Gene Mutation
  • Adenocarcinoma Lung Stage IV
  • Seoul, Korea, Republic of
    Korean Association for the Study of Targeted Therapy
May 23, 2018

Lymphoma Trial in Worldwide (Parsaclisib)

Active, not recruiting
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +82 more
Oct 14, 2022

Acute Ischemic Stroke Trial in China (Alteplase, Tenecteplase)

Recruiting
  • Acute Ischemic Stroke
  • Xuancheng, Anhui, China
  • +62 more
Feb 16, 2023

Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Belantamab Mafodotin)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • Fayetteville, Arkansas
  • +75 more
Aug 11, 2022

Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • Beijing, Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023

Respiratory Tract Infections Trial in Worldwide (Rilematovir, Rilematovir X mg/kg, Placebo)

Terminated
  • Respiratory Tract Infections
  • Orlando, Florida
  • +142 more
Apr 11, 2022

Corneal Haze With Disability Glare

Withdrawn
  • Vision Disability
    • Cleveland, Ohio
      University Hospitals Case Medical Center
    Apr 5, 2022

    MSS, RAS-mutant Colorectal Cancer Trial in Worldwide (binimetinib, nivolumab, ipilimumab)

    Completed
    Has Results
    • MSS
    • RAS-mutant Colorectal Cancer
    • Los Angeles, California
    • +49 more
    Dec 8, 2021

    Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Whittier, California
    • +113 more
    Jan 17, 2023

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Andecaliximab, Nivolumab)

    Completed
    Has Results
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • Los Angeles, California
    • +33 more
    Sep 17, 2020

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Multiple Sclerosis Trial in Seattle (MBCT, CBT)

    Active, not recruiting
    • Multiple Sclerosis
    • MBCT
    • CBT
    • Seattle, Washington
      UW Medicine Multiple Sclerosis Center
    Apr 14, 2022

    NSCLC (NSCLC) Trial in Worldwide (Atezolizumab, Tiragolumab, Durvalumab)

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Tempe, Arizona
    • +254 more
    Aug 8, 2022